chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Local reaction, Rash maculo-papular, Urticaria, Vaccination site erythema
Clinical narrative: 24 hours after vaccine, patient had a localized reaction (at site of vaccination) which progressed to erythematous, urticarial body wide rash. Rash progressively cleared and next 48 hours with residual macula-popular lower extremity exantm.
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Underdose
Clinical narrative: no adverse event; the patient received less than a full dose of PROQUAD; Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent condition and concomitant therapy were not reported.        On 26-JUL-2019, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength, route, lot #, expiration date and indication were not reported) for prophylaxis. The patient received less than a full dose of the vaccine (underdose). No adverse symptoms reported.
Sex: F
Vaccine: HPV9
Symptoms: Exposure during pregnancy
Clinical narrative: GARDASIL 9 was administered to pregnant female; This spontaneous prospective pregnancy report was received from an office manager and refers to a pregnant female patient of unknown age. No information was provided regarding the patients's concomitant medication, medical history, concurrent conditions or drug reactions/allergies.    On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9)  (dose number, route of administration, anatomical injection site, lot# and expiry date were not reported) for prophylaxis. The last menstrual period and estimated delivery date were not known. The pregnancy outcome was pending. The outcome of exposure during pregnancy was unknown.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Herpes Zoster; This spontaneous report was received from a lawyer regarding a case in litigation and referring to a currently 86 years old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On or about 07-AUG-2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose number and route was not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced herpes zoster. On an unspecified date, the patient was treated by a physician for herpes zoster. The outcome of herpes zoster was not reported. The reporter considered the herpes zoster to be related to Zoster Vaccine Live (ZOSTAVAX).
Sex: F
Vaccine: HPV9
Symptoms: Biopsy skin normal, Inflammation, Injection site pain, Therapeutic product effective for unapproved indication
Clinical narrative: mild pain at the injection sites; 9-valent HPV vaccine used in a 98-year-old patient  for treatment of locally metastatic cutaneous basaloid squamous cell carcinoma/ intratumoral doses of the vaccine; This literature marketed report has been received from the authors of a published literature article, titled as stated below and refers to a 98-year-old female patient. The patient had multiple locally metastatic basaloid squamous cell carcinomas (SCCs) on the right leg that recurred 2 years after Mohs surgery. The patient was again treated with Mohs surgery for 4 of the largest lesions. The authors stated that additional surgery was impractical given her tumor burden. She was offered systemic chemotherapy and radiation therapy but declined. The authors reported that due to recent evidence suggests that Human Papilloma Virus (HPV) vaccination may be protective against the development of SCCs in immunocompetent patients and several vaccines are injected intratumorally for other malignancies they initiated treatment with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (manufacturer unknown). On an unknown date, the patient started treatment with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (manufacturer unknown), intramuscularly and intratumorally (strength, exact dose, lot# and expiration date were not reported) for locally metastatic cutaneous basaloid SCCs. The patient developed a local inflammatory response after both the intramuscular and intratumoral doses of the vaccine. Clinical improvement was observed 2 weeks after the second intratumoral dose, with complete resolution confirmed by reflectance confocal microscopy and biopsy 13 months after the first intramuscular dose. On unknown dates, the patient experienced mild pain at the injection sites. The authors stated that aforementioned event was the only side-effect of the treatment. The patient has remained recurrence free for 7 months since her last intratumoral dose. The authors stated that their extraordinary results highlight a novel potential treatment for patients with SCC who were poor surgical candidates. They reported that whether the observed response was specific to HPV or represents a nonspecific immune response was not yet clear. The outcome of the event was not reported. The authors considered pain at the injection sites to be related to HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (manufacturer unknown).   A copy of the published article is attached as further documentation of the patient's experience.
Sex: U
Vaccine: FLUN4, MMRV
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No adverse effects; the patient was inadvertently administered two live virus vaccines within 28 days of one another; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  The patient was inadvertently administered two live virus vaccines within 28 days of one another. On 07-OCT-2013, the patient was vaccinated with the first dose of influenza virus 3v reassortant vaccine live intranasal (cold adapted ann arbor master strain) (FLUMIST) (lot number, expiration date, dose and route of administration were not reported). On 25-OCT-2013, the patient was vaccinated with the first dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot number: J005180, expiration date: 03-NOV-2014; dose and route of administration were not reported) (inappropriate schedule of vaccine administered). No adverse effects were reported.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Incorrect route of product administration, Injection site erythema, Injection site swelling
Clinical narrative: red area at injection site; swollen area at injection site; Believes the vaccine was given subq; This case was reported by a nurse via sales rep and described the occurrence of injection site erythema in a 50-year-old female patient who received Herpes zoster (Shingrix) (batch number 72AA3, expiry date 10th October 2021) for prophylaxis.   On 30th July 2019, the patient received the 1st dose of Shingrix (subcutaneous) .5 ml. On an unknown date, less than 2 weeks after receiving Shingrix, the patient experienced injection site erythema, injection site swelling and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site erythema and injection site swelling were recovered/resolved and the outcome of the intramuscular formulation administered by other route was unknown.   It was unknown if the reporter considered the injection site erythema and injection site swelling to be related to Shingrix.  Additional details were provided as follows: The patient had a reaction and believes the vaccine was given subcutaneously instead of intramuscular, which led to intramuscular formulation administered by other route. The reaction was a red slightly swollen area at injection site the reaction has at the time of reporting were resolved.
Sex: U
Vaccine: HEP
Symptoms: Injection site pain
Clinical narrative: pain at injection site; This case was reported by a nurse via sales rep and described the occurrence of injection site pain in roughly 1949 patient who received HBV (Engerix B 10 mcg) for prophylaxis.  On an unknown date, the patient received Engerix B 10 mcg 10 mg. On an unknown date, less than a year after receiving Engerix B 10 mcg, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Engerix B 10 mcg.  Additional details were provided as follows: The age at vaccination was not applicable. reported. The nurse reported that during the last year the patient had pain at injection site. The reporter did not agree to follow up.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd August 2019, the patient received the 1st dose of Shingrix. In August 2019, less than 2 weeks after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: Lot number and onset date of shingles were unknown. At an unknown time after the 1st dose of Shingrix, the patient developed shingles. The reporter consented to follow up.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; developed shingles; This case was reported by a pharmacist via call center representative and described the occurrence of suspected vaccination failure in an unspecified number of adult patients who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patients received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and Shingrix, the patients experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The lot number and expiry date for Shingrix was not reported. It was reported that there were several patients who experienced shingles after receiving both the doses of Shingrix. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test confirmation for shingles were unknown. The reporter consented to follow-up.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Hypersensitivity, Pruritus, Rash, Swelling
Clinical narrative: Shot on 7/30/19. By Friday 8/2 - area got swollen and itchy - on 8/5 - area still itchy and little swollen. Went to walk in clinic. Diagnosis - allergic rxn. Prescribed Zyrtec and cortisone cream. 8/9/19 - outline of rash still there but much better. Still a little swollen.
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Chills, Diarrhoea, Myalgia, Pain
Clinical narrative: Patient developed chills after shot, then Diarrhea/upset stomach for 4 days. Soreness and muscle pain in shoulder making it painful to lift arm for 1 week.
Age: 23.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Injection site pruritus
Clinical narrative: constant itching where I received my shot
Age: 72.0
Sex: M
Vaccine: FLUR4, VARZOS
Symptoms: Injection site swelling
Clinical narrative: Shingrix   swelling at injection site pt states size of 1/2 baseball
Age: 78.0
Sex: F
Vaccine: UNK
Symptoms: Abdominal discomfort
Clinical narrative: Burning sensation in the abdomen that has continued to persist since the date of the injection
Age: 68.0
Sex: F
Vaccine: FLUA3, VARZOS
Symptoms: Abdominal pain upper, Chills, Headache, Influenza like illness, Migraine
Clinical narrative: Flu like symptoms ( severe chills, shakes, stomach pains). Also report of migraine. severe HA . Symptoms resolved after 24 hours
Age: 68.0
Sex: F
Vaccine: FLUA3, VARZOS
Symptoms: Tremor
Clinical narrative: Flu like symptoms ( severe chills, shakes, stomach pains). Also report of migraine. severe HA . Symptoms resolved after 24 hours
Age: 1.0
Sex: M
Vaccine: MMR, PNC13, VARCEL
Symptoms: Eye swelling, Ocular hyperaemia
Clinical narrative: Swelling/Redness of eyes approx. 10:40am (1 -1/2 hours after injection) on day of injection (8/21/2015). Mom gave Benadryl  at 10:40am. She gave dose of Zyrtec at approx. 10:50 am.  Symptoms improved. No difficulty breathing or speaking.  Advised to continue Benadryl every 6 hours until resolved. ER if difficulty breathing or lip swelling.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Eye pruritus, Pruritus, Rash, Urticaria
Clinical narrative: Patient described a terrible itching in her eyes and palm of her hands, she placed her hands and feet into ice water due to the extreme itching. She woke the next morning with a rash on her torso and a hive on her buttock.  Patient took oral benadryl.  Primary provider advised patient not to receive the second injection of Shingrix.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Anal incontinence, Endoscopy, X-ray normal
Clinical narrative: On 1/24/19 patient began to have multiple accidents he could not control his bowels. He had been fully potty trained since 2 1/2 years old with zero accidents. We have been to numerous doctor appointments and had X-rays and an endoscopy.  He continues to have loss of bowel control with small periods of improvement then worse again. Doctors can not find any other  medical reason for this condition which started between 2-3 days after vaccinations
Age: 73.0
Sex: F
Vaccine: PPV
Symptoms: Peripheral swelling
Clinical narrative: PATIENT HAS A SWOLLEN ARM  ON THE INJECTION ARM BUT NOT AT THE INJECTION SITE
Age: 83.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Body temperature increased, Chills, Gait disturbance, Induration
Clinical narrative: 4X6 inch area of redness surrounding injection site between shoulder and elbow with marked swelling and turgor.   Shivering and chills, extremely weak with difficulty walking 2 blocks to vehicle (was attending an opera at time of onset).  On following day temp was 100.7.  Increased induration and severe malaise on day following injection.  Symptoms gradually decreased over next 3 days.  No respiratory problems tachycardia nor swelling of face or throat.
Age: 83.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Malaise, Skin tightness
Clinical narrative: 4X6 inch area of redness surrounding injection site between shoulder and elbow with marked swelling and turgor.   Shivering and chills, extremely weak with difficulty walking 2 blocks to vehicle (was attending an opera at time of onset).  On following day temp was 100.7.  Increased induration and severe malaise on day following injection.  Symptoms gradually decreased over next 3 days.  No respiratory problems tachycardia nor swelling of face or throat.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Joint range of motion decreased, Pain, Pain in extremity
Clinical narrative: Pt states loss of range of motion while lifting arm over head and sometimes pain in arm doing exercises. He hasn't seen his primary care physician with any complaints.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash
Clinical narrative: Patient developed rash at site.
Age: 37.0
Sex: F
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: 20 min after vaccine, patient reported hives to BL forearms; no airway concerns.  Benadryl 50 mg PO given one time only in clinic.   Transferred to ER immediately, handoff report given to charge RN; at this time patient in nad, A+OX3, breathing spontaneously and effortlessly.  Patient currently in ER at time of VAERS report.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Chest discomfort, Paraesthesia, Pruritus
Clinical narrative: Within 20 minutes patient began prickly feeling over whole body and itching. A little tightness in lungs
Age: 1.0
Sex: M
Vaccine: HEPA, MMRV, PNC13
Symptoms: Blister, Pruritus, Rash
Clinical narrative: rash/ blisters to abdomen...  hydroxyzine solution 10mg/5ml  2.5 ml by mouth every 6 hours as needed prn itching
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Asthenia, Body temperature increased, Chills, Decreased appetite
Clinical narrative: 12 hours after shot, developed 100 degree temperature, chills, headache, nausea, muscle and joint soreness, skin sensitive to touch, loss of appetite,  weakness, difficulty walking, which lasted close to 48 hours.
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Gait disturbance, Headache, Myalgia, Nausea, Pain of skin
Clinical narrative: 12 hours after shot, developed 100 degree temperature, chills, headache, nausea, muscle and joint soreness, skin sensitive to touch, loss of appetite,  weakness, difficulty walking, which lasted close to 48 hours.
Age: 72.0
Sex: F
Vaccine: PPV
Symptoms: Chills, Musculoskeletal pain, Myalgia, Pyrexia
Clinical narrative: Severe chills with fever are the main complaint that made her decide to visit Emergency Room. She also said her deltoid and shoulder are very sore.
Age: 32.0
Sex: F
Vaccine: HEP, HEPA, MMR, TDAP
Symptoms: No adverse event, Underdose
Clinical narrative: Pediatric dose was given to adult patient, no  adverse reaction and no signs or symptoms noted.
Age: 65.0
Sex: M
Vaccine: PPV
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Pt received dose of penumovax 23 before prevnar 13 without any indications
Sex: F
Vaccine: VARZOS
Symptoms: Axillary pain, Breast pain, Herpes zoster, Influenza like illness, Mammogram normal
Clinical narrative: rash under right armpit; pain under right armpit; itching under right armpit; Shingles; pain in right arm and nipple; radiating to right breast and nipple; flu-like symptoms; feverish; This case was reported by a nurse via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st December 2018, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 3rd December 2018, 2 days after receiving Shingrix, the patient experienced shingles, pain in arm, radiating pain, influenza-like symptoms and fever. In January 2019, the patient experienced rash, axillary pain and pruritus. The patient was treated with gabapentin and benadryl (nos) (Benadryl). On an unknown date, the outcome of the shingles was unknown and the outcome of the pain in arm, radiating pain, rash, axillary pain and pruritus were recovering/resolving and the outcome of the influenza-like symptoms and fever were resolved with sequelae.   It was unknown if the reporter considered the shingles, pain in arm, radiating pain, influenza-like symptoms, fever, rash, axillary pain and pruritus to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that within 48 hours of receiving dose 2 of Shingrix, patient was feeling feverish, with flu-like symptoms and pain in the right (non-vaccinated) arm - in the armpit, radiating to right breast and nipple. 8 weeks later, the patient developed a rash in the same area which was accompanied by sunburn-like superficial pain and itching. Mammogram of right breast conducted prior to rash appearance. Results negative. The reporter consented to follow up. Emergency room visit was required.      Lab Comments: On an unknown date mammogram of right breast conducted
Sex: F
Vaccine: VARZOS
Symptoms: Nipple pain, Pain, Pain in extremity, Pruritus, Pyrexia
Clinical narrative: rash under right armpit; pain under right armpit; itching under right armpit; Shingles; pain in right arm and nipple; radiating to right breast and nipple; flu-like symptoms; feverish; This case was reported by a nurse via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st December 2018, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 3rd December 2018, 2 days after receiving Shingrix, the patient experienced shingles, pain in arm, radiating pain, influenza-like symptoms and fever. In January 2019, the patient experienced rash, axillary pain and pruritus. The patient was treated with gabapentin and benadryl (nos) (Benadryl). On an unknown date, the outcome of the shingles was unknown and the outcome of the pain in arm, radiating pain, rash, axillary pain and pruritus were recovering/resolving and the outcome of the influenza-like symptoms and fever were resolved with sequelae.   It was unknown if the reporter considered the shingles, pain in arm, radiating pain, influenza-like symptoms, fever, rash, axillary pain and pruritus to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that within 48 hours of receiving dose 2 of Shingrix, patient was feeling feverish, with flu-like symptoms and pain in the right (non-vaccinated) arm - in the armpit, radiating to right breast and nipple. 8 weeks later, the patient developed a rash in the same area which was accompanied by sunburn-like superficial pain and itching. Mammogram of right breast conducted prior to rash appearance. Results negative. The reporter consented to follow up. Emergency room visit was required.      Lab Comments: On an unknown date mammogram of right breast conducted
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: rash under right armpit; pain under right armpit; itching under right armpit; Shingles; pain in right arm and nipple; radiating to right breast and nipple; flu-like symptoms; feverish; This case was reported by a nurse via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st December 2018, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 3rd December 2018, 2 days after receiving Shingrix, the patient experienced shingles, pain in arm, radiating pain, influenza-like symptoms and fever. In January 2019, the patient experienced rash, axillary pain and pruritus. The patient was treated with gabapentin and benadryl (nos) (Benadryl). On an unknown date, the outcome of the shingles was unknown and the outcome of the pain in arm, radiating pain, rash, axillary pain and pruritus were recovering/resolving and the outcome of the influenza-like symptoms and fever were resolved with sequelae.   It was unknown if the reporter considered the shingles, pain in arm, radiating pain, influenza-like symptoms, fever, rash, axillary pain and pruritus to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that within 48 hours of receiving dose 2 of Shingrix, patient was feeling feverish, with flu-like symptoms and pain in the right (non-vaccinated) arm - in the armpit, radiating to right breast and nipple. 8 weeks later, the patient developed a rash in the same area which was accompanied by sunburn-like superficial pain and itching. Mammogram of right breast conducted prior to rash appearance. Results negative. The reporter consented to follow up. Emergency room visit was required.      Lab Comments: On an unknown date mammogram of right breast conducted
Sex: F
Vaccine: VARZOS
Symptoms: Malaise
Clinical narrative: Malaise/not feeling well; This case was reported by a pharmacist via call center representative and described the occurrence of malaise in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced malaise. On an unknown date, the outcome of the malaise was unknown.   It was unknown if the reporter considered the malaise to be related to Shingrix.  Additional details were provided as follows: The batch number was not reported. The pharmacist on the line stating a physician called in to report that the patient received Shingrix and had severe malaise for a week to 10 days. The patient basically did not feel well.  The reporter consented to follow up. The caller has no further details and further patient identifiers. No further information regarding responsible physician was provided.
Age: 7.0
Sex: M
Vaccine: IPV, MMR, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: Pt came in for well child exam August 19,2019 with father. No complaints at this time. Father reports son just moved from another country was starting school. Vaccines were given. Father reports August 20,2019 at 6pm son reports he complained of his left arm itching. Father reports left upper arm was red and warm to touch. Father denies any fever, nausea, change in behavior, or rash anywhere else. This morning father took a picture of area and sent child to school. After school, father reports son said area was still itching. Father brought son into clinic. Son was seen by Nurse practitioner. Exam as follows- mild erythema and warmth noted to left deltoid. No fever, tachycardia, or shortness of breath noted. Area was circled with a pen, Informed father to monitor redness and if it spread, to bring child pt to clinic. Father understood. Educated on cool compress and anti-itch cream prn.
Age: 12.0
Sex: F
Vaccine: MENB, TDAP
Symptoms: Syncope
Clinical narrative: Fainting after several minutes
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Headache, Injection site pain, Nausea
Clinical narrative: Experienced soreness in injection site  just like I experienced after first injection  which was received on June 7, 2019.  Unlike the first injection, this time I felt extreme fatigue at bedtime.  Around 2 AM I awoke with a headeache and nausea.  I vomited and continued to feel nauseous with a headache for the rest of the night.  The following  day I had chills and  felt fatigued all day.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Vomiting
Clinical narrative: Experienced soreness in injection site  just like I experienced after first injection  which was received on June 7, 2019.  Unlike the first injection, this time I felt extreme fatigue at bedtime.  Around 2 AM I awoke with a headeache and nausea.  I vomited and continued to feel nauseous with a headache for the rest of the night.  The following  day I had chills and  felt fatigued all day.
Age: 0.75
Sex: M
Vaccine: DTAPIPVHIB, HEPA, MMR, PNC13, VARCEL
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: DOB was incorrect so nurse thought patient was 12 month old and not 9 month and gave vaccines according to 12 month old schedule
Age: 6.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Injection site pruritus, Injection site reaction, Rash erythematous
Clinical narrative: Patient with mother; presented with 5x4 cm raised reddish rash in left upper arm noted yesterday. Pt had Kinrix injection in left upper arm 2 days ago. Pt denies pain except for mild itchiness. No other symptoms.        Right upper arm site for Proquad injection has no reaction.
Age: 4.0
Sex: F
Vaccine: MMRV
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: redness and warmth at the site
Age: 0.25
Sex: M
Vaccine: RV1
Symptoms: Abdominal X-ray, Abdominal distension, Ascites, Chest X-ray abnormal, Diarrhoea haemorrhagic
Clinical narrative: 1 month after vaccination with rotarix , pediarix, hepb hib, pcv13 patient presented with bloody diarrhea. Patient diagnosed with the following:  (08/11 2058):,   X-ray showed, "Diffuse moderate to severe gaseous distention of bowel loops throughout the abdomen, consistent with obstruction.   Ultrasound performed the same day demonstrated, "An ileocolic intussusception.  There is an ileocolic intussusception with target sign (approximately 3.3 cm in diameter) noted in the right upper quadrant.  There is fluid trapped in the intussusception.  There is a large echogenic fatty core.  There is a small volume of simple ascites in the right upper quadrant.  Low lung volumes with diffuse hazy opacities.  No focal consolidations."  on 8/12: Ileocecal resection with primary anastomosis.  with ex lap after failure of
Age: 0.25
Sex: M
Vaccine: RV1
Symptoms: Explorative laparotomy, Intestinal anastomosis, Intestinal obstruction, Intestinal resection, Intussusception
Clinical narrative: 1 month after vaccination with rotarix , pediarix, hepb hib, pcv13 patient presented with bloody diarrhea. Patient diagnosed with the following:  (08/11 2058):,   X-ray showed, "Diffuse moderate to severe gaseous distention of bowel loops throughout the abdomen, consistent with obstruction.   Ultrasound performed the same day demonstrated, "An ileocolic intussusception.  There is an ileocolic intussusception with target sign (approximately 3.3 cm in diameter) noted in the right upper quadrant.  There is fluid trapped in the intussusception.  There is a large echogenic fatty core.  There is a small volume of simple ascites in the right upper quadrant.  Low lung volumes with diffuse hazy opacities.  No focal consolidations."  on 8/12: Ileocecal resection with primary anastomosis.  with ex lap after failure of
Age: 0.25
Sex: M
Vaccine: RV1
Symptoms: Procedural failure, Ultrasound abdomen abnormal, X-ray abnormal
Clinical narrative: 1 month after vaccination with rotarix , pediarix, hepb hib, pcv13 patient presented with bloody diarrhea. Patient diagnosed with the following:  (08/11 2058):,   X-ray showed, "Diffuse moderate to severe gaseous distention of bowel loops throughout the abdomen, consistent with obstruction.   Ultrasound performed the same day demonstrated, "An ileocolic intussusception.  There is an ileocolic intussusception with target sign (approximately 3.3 cm in diameter) noted in the right upper quadrant.  There is fluid trapped in the intussusception.  There is a large echogenic fatty core.  There is a small volume of simple ascites in the right upper quadrant.  Low lung volumes with diffuse hazy opacities.  No focal consolidations."  on 8/12: Ileocecal resection with primary anastomosis.  with ex lap after failure of
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash, Rash vesicular
Clinical narrative: Patient developed a rash that resembles shingles on his right upper thigh a few days after his first Shingrix vaccine. The rash doesn't itch or burn, and is currently not having any complications from the rash.
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash macular, Sensitive skin
Clinical narrative: Within 8 hours developed sensitive area of skin on the left chest area. In 24 hours after that 3 small reddish blotches formed in the same chest area.  The area of sensitivity developed over the entire left side of the chest area the next 48 hours.  Skin sensitivity also was present on the inside of the left arm near the elbow.  After 6 days additional reddish blotches began to form in a line from the front chest area of the original ones around the side of the chest to the back.   The Doctor confirmed that I had developed shingles.
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Dizziness, Pallor, Visual impairment
Clinical narrative: Pt felt dizzy, became pale, and saw black spots 2 min post administration of vaccine. No LOC, no nausea or vomiting. Pt responding normal- no signs of an allergic reaction. Laid pt back and elevated legs, put an ice pack on and checked vitals. BP: 91/57, pulse 66 at 3:50 pm, 3:56 pm BP: 95/60 , P: 67. Pt ate lunch prior to vaccine- sucker given during it- pt drank apple juice after reaction. Kept pt in office X 30 min total and left with mom after pt was stable and had no dizziness, not seeing black spots anymore and color returned. discharge vitals 4:12 pm:  BP: 95/63, P: 69
Age: 62.0
Sex: F
Vaccine: FLU4, VARZOS
Symptoms: Dizziness, Headache, Mobility decreased, Pain
Clinical narrative: She said she experienced headache, dizziness, and body aches. She could not get out of bed
Age: 11.0
Sex: M
Vaccine: HPV9, MNQ, TDAP
Symptoms: Cellulitis
Clinical narrative: Cellulitis's
Age: 61.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site pain, Pain
Clinical narrative: Redness at the site, soreness, pain at the site as well. Started about a day after vaccine.
Age: 61.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site pain, Pain, Swelling
Clinical narrative: Redness at the site, soreness, pain at the site as well. Started about a day after vaccine.
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Delirium, Dizziness, Faeces soft
Clinical narrative: Shoulder sore immediately and increasingly (11:00 AM).  Flu symptoms began within a couple hours.  First, skin/scalp soreness.  In the evening, I began to feel feverish, had a headache, chills, and dizzy/delirious sensations.  At midnight, I had a fever of 101.6.  At 7:20 AM (following day), temp. was down to 99.8.  At 8:15 I broke into a sweat and felt faint.  I had to hurry to the bathroom, where I had a bowel movement that began firm but then turned very soft.  At 8:30, temp was down to 99.1.  I had no energy, so i rested/napped for a couple hours.  By 11:30 I had eaten and remaining symptoms were mild--muscle and scalp soreness, slight headache.  By mid-afternoon, I was again drained of energy and napped for about two hours, very uncommon for me.  Spent a quiet evening, and the next morning, I was feeling almost normal again.
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Hyperhidrosis, Immediate post-injection reaction, Influenza, Musculoskeletal pain
Clinical narrative: Shoulder sore immediately and increasingly (11:00 AM).  Flu symptoms began within a couple hours.  First, skin/scalp soreness.  In the evening, I began to feel feverish, had a headache, chills, and dizzy/delirious sensations.  At midnight, I had a fever of 101.6.  At 7:20 AM (following day), temp. was down to 99.8.  At 8:15 I broke into a sweat and felt faint.  I had to hurry to the bathroom, where I had a bowel movement that began firm but then turned very soft.  At 8:30, temp was down to 99.1.  I had no energy, so i rested/napped for a couple hours.  By 11:30 I had eaten and remaining symptoms were mild--muscle and scalp soreness, slight headache.  By mid-afternoon, I was again drained of energy and napped for about two hours, very uncommon for me.  Spent a quiet evening, and the next morning, I was feeling almost normal again.
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Myalgia, Pain of skin, Pyrexia, Somnolence
Clinical narrative: Shoulder sore immediately and increasingly (11:00 AM).  Flu symptoms began within a couple hours.  First, skin/scalp soreness.  In the evening, I began to feel feverish, had a headache, chills, and dizzy/delirious sensations.  At midnight, I had a fever of 101.6.  At 7:20 AM (following day), temp. was down to 99.8.  At 8:15 I broke into a sweat and felt faint.  I had to hurry to the bathroom, where I had a bowel movement that began firm but then turned very soft.  At 8:30, temp was down to 99.1.  I had no energy, so i rested/napped for a couple hours.  By 11:30 I had eaten and remaining symptoms were mild--muscle and scalp soreness, slight headache.  By mid-afternoon, I was again drained of energy and napped for about two hours, very uncommon for me.  Spent a quiet evening, and the next morning, I was feeling almost normal again.
Age: 14.0
Sex: M
Vaccine: HEPA
Symptoms: Dizziness, Hyperhidrosis, Hypoaesthesia, Skin discolouration, Tinnitus
Clinical narrative: Client become diaphoretic, grey in color, and nauseated approximately 1 minute after administration of the Hepatitis A vaccine. Client attempted to walk from chair to the exam table to lay down and had to lay down in the middle of the hallway due to becoming dizzy and lightheadeded. Client reported ringing in his ears and numbness to the right upper extremity. Good circulation to right upper extremity noted.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Dysstasia, Gait disturbance, Headache
Clinical narrative: On the night of the day I received the vaccination, my left arm (where the shot was) began to feel stiff and painful - down to my hand. My body began aching horribly, especially from the waist down; it was difficult to move and/or stand up and walk. I began having chills and running a fever (around 101),  and had a headache. I was very weak. I could not function to work, etc.  The symptoms continued to increase through the night and the whole next day. And, as I am writing this I am still very symptomatic. I am feeling like this may continue for at least another day - at this point. And, based on what I have read the side effects can last up to a few days.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Impaired work ability, Injection site pain, Mobility decreased, Musculoskeletal stiffness, Pain
Clinical narrative: On the night of the day I received the vaccination, my left arm (where the shot was) began to feel stiff and painful - down to my hand. My body began aching horribly, especially from the waist down; it was difficult to move and/or stand up and walk. I began having chills and running a fever (around 101),  and had a headache. I was very weak. I could not function to work, etc.  The symptoms continued to increase through the night and the whole next day. And, as I am writing this I am still very symptomatic. I am feeling like this may continue for at least another day - at this point. And, based on what I have read the side effects can last up to a few days.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: On the night of the day I received the vaccination, my left arm (where the shot was) began to feel stiff and painful - down to my hand. My body began aching horribly, especially from the waist down; it was difficult to move and/or stand up and walk. I began having chills and running a fever (around 101),  and had a headache. I was very weak. I could not function to work, etc.  The symptoms continued to increase through the night and the whole next day. And, as I am writing this I am still very symptomatic. I am feeling like this may continue for at least another day - at this point. And, based on what I have read the side effects can last up to a few days.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Altered state of consciousness, Blood test, Chest X-ray, Chills
Clinical narrative: On 8/17/19 patient felt aches and chills. Patient had fever through the night.  The next morning, patient had upset stomach and felt tired.  About 11am patient was sweating and felt like she was going to pass out.  Paramedics were called.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Computerised tomogram, Echocardiogram, Fatigue, Hyperhidrosis, Nuclear magnetic resonance imaging
Clinical narrative: On 8/17/19 patient felt aches and chills. Patient had fever through the night.  The next morning, patient had upset stomach and felt tired.  About 11am patient was sweating and felt like she was going to pass out.  Paramedics were called.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Pyrexia, Ultrasound Doppler
Clinical narrative: On 8/17/19 patient felt aches and chills. Patient had fever through the night.  The next morning, patient had upset stomach and felt tired.  About 11am patient was sweating and felt like she was going to pass out.  Paramedics were called.
Age: 13.0
Sex: M
Vaccine: HPV9
Symptoms: Headache, Photophobia, Visual impairment
Clinical narrative: Pounding headache, visual disturbances, sensitivity to light
Age: 14.0
Sex: M
Vaccine: HPV9
Symptoms: Seizure, Syncope
Clinical narrative: fainted & slight seizure
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: Facial paralysis
Clinical narrative: Bell's palsy diagnosis by PCH. Left side of her face was paralized for about 30 days. No control of left side at all.
Age: 69.0
Sex: M
Vaccine: VARZOS
Symptoms: Flushing
Clinical narrative: ON 8/20/19 PATIENT MADE US AWARE THAT APPROXIMATELY 5 HOURS AFTER RECEIVING SHINGRIX INJECTION ON 8/7/19 FOR THE FIRST TIME HE DEVELOPED A GENERALIZED FLUSHING EFFECT THROUGH OUT HIS BODY THAT LASTED 3 DAYS. HE STATED HE DID NOT HAVE FEVER, BUT JUST FLUSHING.
Age: 85.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Confusional state, Decreased appetite, Injection site warmth
Clinical narrative: Patient is experiencing confusion, loss of appetite, and warmness around injection site. I told patient's daughter that injection site reactions are common as well as low grade fever, nauseousness, etc. If it continues/worsens, she should seek medical care.
Age: 72.0
Sex: F
Vaccine: FLUA3, VARZOS
Symptoms: Chills, Erythema, Flushing, Headache, Injection site erythema
Clinical narrative: Patient was unable to sleep last night because she experienced flushing/ redness with fever/chills all night. She has some slight redness around injection sites but nothing major. She was feeling better today but now has a minor headache.
Age: 72.0
Sex: F
Vaccine: FLUA3, VARZOS
Symptoms: Insomnia, Pyrexia
Clinical narrative: Patient was unable to sleep last night because she experienced flushing/ redness with fever/chills all night. She has some slight redness around injection sites but nothing major. She was feeling better today but now has a minor headache.
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Anxiety, Pain in extremity, Presyncope
Clinical narrative: Patient was seated for Shingrix vaccine. I talked to patient for a few minutes after administration then she stood up from chair and walked to register. While waiting in register line she stated "I think I need to sit down".  I recognized patient was about to faint and caught her while she was walking back to the immunization area.  Kept patient laying on ground for approximately 5 minutes and then moved patient to chair. Patient stated she had fainted in the past when giving blood but never from a vaccine. She stated that she thinks she fainted from "getting worked up about the vaccine and the pain she felt". I moved patient to chair when she was ready and store manager gave her orange juice. She sat in chair for another 5-10 minutes. Patient stated she felt fine so the store manager and I walked her to her car. She stated she was going to sit in her car with the air conditioning on for awhile. Spoke to patient an hour after event and she said she felt fine just had the expected arm soreness.
Age: 59.0
Sex: M
Vaccine: VARZOS
Symptoms: Oral discomfort, Rash, Swelling face
Clinical narrative: Patient reported swelling under the eye along with a rash under the eye and discomfort on the roof of his mouth.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: Muscle pain, feeling tired and weak, Shivering, fever.
Age: 62.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Asthenia, Chills, Influenza like illness, Pain
Clinical narrative: Body aches, chills (poss fever, though I didn't temp myself), low energy, felt almost like a low grade flu.  Onset: several hours after injection.  Duration: about 36-48 hours.  Outcome:  self-resolved without issue.
Age: 62.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Asthenia, Chills, Influenza like illness, Pain
Clinical narrative: Same as with Shingrix vaccination 1 of 2, body aches, chills (poss fever, though I didn't temp myself), low energy, felt almost like a low grade flu.  Onset: several hours after injection.  Duration: about 36-48 hours.  Outcome:  self-resolved without issue.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Balance disorder, Dyspnoea, Sensation of foreign body, Sensory disturbance
Clinical narrative: Patient called the pharmacy on 8/21/19 to report a serious reaction to the Shingrix vaccine she received on 8/16/19. Patient went to her MD today and they said patient should report her reaction to the pharmacy so we could submit to VAERS. Patient reported feeling warm liquid going through left side of her brain, breathing issues, knot in the throat, and an off balance feeling beginning within 5 minutes of receiving vaccine. Patient reports improvement of all symptoms since the event but still having some balance issues.
Age: 43.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: patient had itchiness, redness, swelling, and pain to site where vaccine was given. Patient was given Medrol 4mg tablets and Methylprednisolone 125/2ml on 8/21/2019.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Feeling cold
Clinical narrative: Severe shivering and cold feeling .  Could not feel warm even with fleece jacket and several blankets.   Shivering continued from 8 pm on 8/19/2019 until noon on 8/20/2019.   Took ibuprofen stayed in bed with blankets.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: localized swelling, tenderness, redness at the injection site. no systemic symptoms such as fever. advised patient that this is a commonly reported side effect and to monitor. if it worsens, seek care and contact PCP tomorrow.
Age: 4.0
Sex: M
Vaccine: DTAPIPVHIB, IPV
Symptoms: Erythema, Fatigue, Irritability, Skin warm, Swelling
Clinical narrative: Swelling, redness, hot to touch, irritable, tiredness
Age: 51.0
Sex: M
Vaccine: VARZOS
Symptoms: Injected limb mobility decreased, Pain in extremity
Clinical narrative: Patient's wife reported that after the shot, patient's left arm is sore. after 2 hours, he can't lift up his left arm.  The arm is not swollen or red. Patient started taking Naproxen on 8/20/19 but has not been resolved.  He started doing hot compresses twice for 20-30 minutes at the time of reporting at 11:00 AM 8/21/19
Age: 17.0
Sex: M
Vaccine: MENB
Symptoms: Erythema, Muscle tightness, Pain, Swelling
Clinical narrative: Pain and muscle tightening, swelling and redness in shoulder
Age: 84.0
Sex: F
Vaccine: VARZOS
Symptoms: Musculoskeletal pain, Neck pain
Clinical narrative: At around 10 am patient received shingrix vaccine.  At around 1 pm she said that she started to get exceptional pain in her shoulder and neck. She informed the pharmacy of this at 4 pm.  I told her to take some ibuprofen and rotate applying heat and cold.  I told her to call us back at 7 pm.  I ended up speaking to her at 7:30 pm and she said that her pain had improved a lot since the afternoon. I told her to call pharmacy tomorrow if her pain does not continue to improve or if it gets worse.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Nausea, Retching
Clinical narrative: nausea as well as dry heaving
Age: 59.0
Sex: F
Vaccine: FLU4
Symptoms: Confusional state, Headache, Memory impairment, Unresponsive to stimuli
Clinical narrative: Pt states that about 45 minutes after receiving vaccine, they had a headache.  Then they do not remember much of the afternoon...almost like their mind was blank.  Pt did state that they have psychomotor seizures.    1) was driving across down but stopped car on the side of the road . Other people noticed the stopped car and tried to talk to her - no response (even though she seemed alert) 2) pt's husband found her trying to iron a shirt but instead of an iron she was using reading glasses. 3) cannot remember doing anything during the after noon.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Injection site erythema, Injection site swelling, Injection site warmth, Pyrexia
Clinical narrative: Fever over 100.5 first 24 hours.   Fever 99.5 second day.   Joint aches and pains. Swelling and increased temperature and redness at injection site for 2-3 days and upper arm
Age: 75.0
Sex: M
Vaccine: PPV
Symptoms: Chills, Mobility decreased, Musculoskeletal pain, Pyrexia
Clinical narrative: Severe chills, some fever and Very sore shoulder with difficulty raising arm.
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: Erythema, Rash, Rash erythematous
Clinical narrative: PATIENT COMPLAINS OF A BILATERAL RED RASH ON UPPER EXTREMITIES AND UPPER CHEST. REDDNESS SHOWED UP THIS EVENING AFTER HIS SHOWER. NO ITCHING, NO ORAL SWELLING, NO HIVES, NO TROUBLE BREATHING INVOLVED.  I RECOMMENDED THAT HE CONSIDER TAKING AN ANTIHISTAMINE SUCH AS BENADRYL OR CLARITIN AND TO REACH OUT TO HIS PRIMARY CARE DOCTOR. IF HIS SYMPTOMS WORSEN HE SHOULD SEEK CARE AT THE HOSPITAL.